Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parameters.

Saved in:
Bibliographic Details
Title: Urokinase and plasminogen activator-inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function of histopathological parameters.
Authors: Hoffmann G; St. Josef's Hospital, Wiesbaden, Germany., Pollow K, Weikel W, Strittmatter HJ, Bach J, Schaffrath M, Knapstein P, Melchert F, Pollow B
Source: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 1999 Jan; Vol. 37 (1), pp. 47-54.
Publication Type: Journal Article
Journal Info: Publisher: Walter De Gruyter Country of Publication: Germany NLM ID: 9806306 Publication Model: Print Cited Medium: Print ISSN: 1434-6621 (Print) Linking ISSN: 14346621 NLM ISO Abbreviation: Clin Chem Lab Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1434-6621
DOI:10.1515/CCLM.1999.007